Denmark Becomes First EU Nation Certified by WHO for Eliminating Mother-to-Child Transmission of HIV and Syphilis

In a landmark achievement for public health, the World Health Organization (WHO) has officially certified Denmark for the elimination of mother-to-child transmission (EMTCT) of HIV and syphilis. This prestigious recognition underscores Denmark’s unwavering and sustained commitment to ensuring that every child is born free from these preventable infections, setting a significant precedent within the European Union and globally. The announcement marks the culmination of decades of dedicated effort, robust healthcare policies, and a comprehensive approach to maternal and child health.

The Milestone Achievement: A Public Health Triumph

The certification, announced following rigorous assessments by WHO’s Regional Validation Committee in June 2025 and the Global Validation Advisory Committee (GVAC) in August 2025, confirms that Denmark has met all requisite targets consistently from 2021 to 2024. These targets include maintaining exceptionally low transmission rates of HIV and syphilis from mothers to their children, alongside achieving high coverage of prenatal testing and treatment for all pregnant women. This accomplishment signifies not merely a reduction but a virtual eradication of new pediatric cases of these diseases, ensuring healthier starts for countless lives.

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, lauded the achievement, stating, "The elimination of mother-to-child transmission of HIV and syphilis marks a major public health achievement for Denmark. This milestone demonstrates that with strong political commitment and consistent investment in primary care and integrated maternal and child health services, countries can protect every pregnant woman and newborn from these diseases." His words highlight the replicable blueprint Denmark has established, emphasizing that political will, coupled with strategic healthcare investment, forms the bedrock of such successes.

A Decades-Long Journey: Denmark’s Commitment to Maternal and Child Health

Denmark’s journey to this public health pinnacle is not an overnight success but rather the result of sustained commitment spanning several decades. The nation has long been recognized for its robust welfare state and its universal healthcare system, which provides equitable access to high-quality medical services for all citizens, regardless of socioeconomic status. This foundational principle of universal access has been pivotal in creating an environment where comprehensive antenatal care, including screening and treatment for infectious diseases, is a standard offering for every pregnant woman.

Historically, Denmark began implementing systematic prenatal screening programs decades ago, gradually refining its strategies in line with evolving medical knowledge and WHO guidelines. Early detection and intervention for conditions like HIV and syphilis became integral components of routine maternal health services. This involved not just testing but also ensuring immediate access to effective treatment for mothers, thereby interrupting the transmission pathway to their infants. The continuous evolution of these programs, bolstered by public health campaigns and a highly trained healthcare workforce, has been instrumental in progressively reducing incidence rates over time. This long-term strategic vision, focusing on prevention and early intervention, laid the groundwork for the current elimination status.

Understanding Mother-to-Child Transmission (MTCT): The Global Context

Mother-to-child transmission, also known as vertical transmission, refers to the passage of an infection from a mother to her child during pregnancy, childbirth, or breastfeeding. HIV and syphilis are two of the most significant infections that can be transmitted in this manner, leading to severe health consequences for infants.

Globally, HIV remains a major public health challenge, with millions of children born with the virus, primarily in sub-Saharan Africa, despite significant progress in preventing MTCT. Without intervention, the risk of an HIV-positive mother transmitting the virus to her child can range from 15% to 45%. This risk can be reduced to less than 5% with effective antiretroviral treatment (ART) during pregnancy, delivery, and breastfeeding for the mother, and prophylactic ART for the newborn. Pediatric HIV, if left untreated, can lead to severe immunosuppression, opportunistic infections, and high mortality rates in early childhood.

Similarly, congenital syphilis, caused by the transmission of Treponema pallidum from an infected pregnant woman to her fetus, can have devastating outcomes. Without timely diagnosis and treatment, congenital syphilis can result in stillbirth, neonatal death, prematurity, low birth weight, and a range of severe health problems in surviving infants, including bone deformities, neurological impairments, and sensory deficits. The global burden of congenital syphilis remains substantial, particularly in regions with limited access to antenatal care and screening. WHO estimates that, globally, untreated maternal syphilis results in approximately 300,000 fetal and neonatal deaths and 215,000 infants born with congenital syphilis each year.

The WHO’s EMTCT initiative is a critical global effort aimed at eliminating these preventable transmissions, thereby safeguarding the health and future of children worldwide. Denmark’s certification serves as a powerful testament to the feasibility of this goal even in high-income settings, highlighting the importance of robust public health infrastructure.

The Rigorous Validation Process

Achieving WHO validation for EMTCT is a stringent process that demands not only low transmission rates but also high-quality, sustained public health interventions. The validation framework requires countries to meet a set of specific epidemiological and programmatic criteria for at least four consecutive years. For Denmark, this period spanned from 2021 to 2024.

Key programmatic benchmarks include:

• High Coverage of Antenatal Care (ANC): Ensuring that at least 95% of pregnant women attend at least four ANC visits.
• High Coverage of HIV and Syphilis Testing: At least 95% of pregnant women receive testing for HIV and syphilis.
• High Coverage of Treatment: At least 95% of HIV-positive pregnant women receive antiretroviral therapy, and at least 95% of syphilis-positive pregnant women receive appropriate penicillin treatment.
• Low Mother-to-Child Transmission Rates: Maintaining a rate of less than 2% for HIV and less than 0.5 cases of congenital syphilis per 1,000 live births.
• Robust Surveillance Systems: Demonstrating the capacity to accurately collect, analyze, and report data on HIV and syphilis cases in pregnant women and children.

Dr. Hans Henri P. Kluge, WHO Regional Director for Europe, elaborated on these benchmarks: "Elimination means testing and treating at least 95 out of every 100 pregnant women — and keeping new infant infections below 50 per 100,000 births, year after year. Denmark has met these benchmarks through strong antenatal care, reliable data systems, and respect for women’s rights." The meticulous assessment by the Regional and Global Validation Committees confirmed Denmark’s adherence to these demanding standards, underscoring the reliability and effectiveness of its public health infrastructure and its commitment to human rights in healthcare delivery.

Pillars of Success: What Made Denmark’s Achievement Possible?

Denmark’s success in eliminating mother-to-child transmission of HIV and syphilis can be attributed to several interconnected factors, forming a comprehensive and resilient public health ecosystem:

1. Universal Health Coverage (UHC): The cornerstone of Denmark’s healthcare system is its commitment to UHC, ensuring that all residents have equal access to necessary health services without financial hardship. This means that prenatal care, including HIV and syphilis screening and treatment, is available and affordable for every pregnant woman, eliminating socioeconomic barriers that often impede access in other regions.

2. Integrated Maternal and Child Health Services: Denmark has successfully integrated screening and treatment for HIV and syphilis into its routine maternal and child health services. This ‘one-stop shop’ approach simplifies access for pregnant women, ensuring that they receive comprehensive care from a single point of contact, reducing the chances of missed diagnoses or delayed treatment. Midwives and general practitioners play crucial roles as primary points of contact, facilitating early and continuous engagement with the healthcare system.

3. Robust Screening and Treatment Protocols: The country implements standardized and highly effective screening protocols for all pregnant women. This includes routine testing for both HIV and syphilis at the earliest stages of pregnancy, with provisions for repeat testing where clinically indicated. Coupled with rapid diagnostic capabilities, this allows for prompt initiation of treatment. Denmark’s robust laboratory capacity ensures accurate and timely testing, a critical factor in effective disease management.

4. Strong Data Systems and Surveillance: Exemplary data systems are vital for monitoring disease prevalence, tracking treatment outcomes, and identifying any potential gaps in service delivery. Denmark’s sophisticated health registries and surveillance mechanisms allow for meticulous data collection and analysis, providing real-time insights into the effectiveness of its EMTCT programs. This data-driven approach enables continuous quality improvement and targeted interventions.

5. Respect for Women’s Rights and Patient-Centered Care: The Danish healthcare system operates with a strong emphasis on women’s rights, confidentiality, and informed consent. This creates a trusting environment where pregnant women feel comfortable seeking and adhering to care, without fear of stigma or discrimination. The system respects individual autonomy while ensuring access to the best possible medical outcomes.

6. Highly Skilled Healthcare Workforce: The dedication and expertise of Denmark’s clinical and public health professionals—including doctors, nurses, midwives, and laboratory technicians—have been indispensable. Their commitment to evidence-based practices, continuous education, and patient advocacy forms the human backbone of this public health triumph.

Voices of Leadership: Official Reactions and Endorsements

The achievement has been met with widespread acclaim from both national and international health leaders. Sophie Løhde, Minister for the Interior and Health, Denmark, expressed immense pride: "This validation by WHO is a proud moment for Denmark and the result of decades of work by our health-care professionals, midwives, and public health teams to ensure that every pregnant woman receives the screening and care she needs." She further emphasized the foundational role of Denmark’s universal health system, built on equal access for all, in making this achievement possible. "Being the first country in the European Union to reach this milestone is both an honour and a responsibility. We hope our experience can inspire and support other countries on their path to elimination, and we look forward to completing the journey with the addition of hepatitis B to achieve full triple elimination."

These statements collectively underscore the collaborative nature of this success, crediting not just political leadership but also the tireless efforts of frontline healthcare workers and the inherent strength of a system designed for equity.

Detailed Data Snapshot: Denmark’s Epidemiological Landscape

The effectiveness of Denmark’s public health efforts is reflected in its remarkably low prevalence rates for these infections. Approximately 5,950 people are living with HIV in Denmark, and less than 0.1% of pregnant women are affected. Through routine testing and treatment, mother-to-child transmission has been effectively reduced to zero.

For syphilis, while 626 cases were reported overall in 2024, the vast majority (524) were in men, with only 102 cases in women. Congenital syphilis is exceedingly uncommon due to systematic prenatal screening and care, indicating a highly effective prevention cascade.

Regarding hepatitis B (HBV), the prevalence of chronic infection is estimated at around 0.2%–0.3%, primarily among migrants from endemic regions. These low infection rates across the board highlight the comprehensive nature and success of Denmark’s public health interventions and prenatal care system.

Looking Ahead: The Triple Elimination and Global Implications

Denmark’s journey does not end with HIV and syphilis. The country is already well on track towards validating the elimination of mother-to-child transmission of the hepatitis B virus (HBV). This would lead to a "triple elimination" status, a more comprehensive public health victory that few countries have achieved. WHO is actively collaborating with Denmark in advancing this triple elimination validation process, recognizing the nation’s capacity and commitment.

The implications of Denmark’s achievement extend far beyond its borders. As the first European Union country to reach this public health milestone, Denmark serves as a beacon of inspiration and a practical model for other EU member states and nations worldwide. Its experience demonstrates what is truly possible when rights-based policies, high-quality services, and robust data systems converge. It offers tangible lessons in strengthening EMTCT programs, particularly concerning the importance of universal access, integrated care, and a human rights approach.

Denmark now joins a distinguished group of 22 other countries and territories globally that have been validated by WHO for the elimination of mother-to-child transmission of HIV, syphilis, or hepatitis B, or are certified on the path to elimination. This list includes Anguilla, Antigua and Barbuda, Armenia, Belarus, Belize, Bermuda, Brazil, Botswana, Cayman Islands, Cuba, Dominica, Jamaica, Malaysia, Maldives, Montserrat, Namibia, Oman, Republic of Moldova, Saint Vincent and the Grenadines, Sri Lanka, St. Kitts and Nevis, and Thailand. Each of these nations, now including Denmark, contributes to a growing global narrative of public health success, proving that with strategic investment and unwavering dedication, the dream of a generation born free from these preventable infections can indeed become a reality. This collective progress provides significant momentum for global health initiatives, offering hope and practical strategies for countries still grappling with the burden of mother-to-child transmission.

The WHO’s certification of Denmark is more than just a recognition of past efforts; it is a powerful call to action and a testament to the enduring impact of robust public health systems. It signifies a profound legacy for Danish children, ensuring they are afforded the fundamental right to a healthy start in life, free from the shadow of HIV and syphilis.